REFERENCES

1. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol 2009;8:643-53.

2. Federico A, Di Donato I, Bianchi S, Di Palma C, Taglia I, et al. Hereditary cerebral small vessel diseases: a review. J Neurol Sci 2012;322:25-30.

3. Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. Am J Neuroradiol 2005;26:2481-7.

4. Tikka S, Baumann M, Siitonen M, Pasanen P, Pöyhönen M, et al. CADASIL and CARASIL. Brain Pathol 2014;24:525-44.

5. Kalman B, Leist TP. Familial multiple sclerosis and other inherited disorders of the white matter. Neurologist 2004;10:201-15.

6. O’Riordan S, Nor AM, Hutchinson M. CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler 2002;8:430-2.

7. Coto E, Menéndez M, Navarro R, García-Castro M, Alvarez V. A new de novo Notch3 mutation causing CADASIL. Eur J Neurol 2006;13:628-31.

8. Pescini F, Nannucci S, Bertaccini B, Salvadori E, Bianchi S, et al. The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke 2012;43:2871-6.

9. He D, Chen D, Li X, Hu Z, Yu Z, et al. The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients and population-specific evaluation of CADASIL scale in China. J Headache Pain 2016;17:55.

10. Pandey T, Abubacker S. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: an imaging mimic of multiple sclerosis. A report of two cases. Med Princ Pract 2006;15:391-5.

11. Paraskevas GP, Bougea A, Synetou M, Vassilopoulou S, Anagnostou E, et al. CADASIL and autoimmunity: coexistence in a family with the R169C mutation at exon 4 of the NOTCH3 gene. Cerebrovasc Dis 2014;38:302-7.

12. Paraskevas GP, Constantinides VC, Bougea A, Gerakoulis E, Yapijakis C, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy presenting with postpartum psychosis and late-onset stroke. Future Neurol 2016;1:207-13.

13. Joshi S, Yau W, Kermode A. CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. J Clin Neurosci 2017;35:75-7.

14. Carone DA. CADASIL and multiple sclerosis: A case report of prolonged misdiagnosis. Appl Neuropsychol Adult 2017;24:294-7.

15. Broadley SA, Sawcer SJ, Chataway SJ, Coraddu F, Coles A, et al. No association between multiple sclerosis and the Notch3 gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neurol Neurosurg Psychiatry 2001;71:97-9.

16. Del Río Espínola A, Solé E, Montaner J. Pathophysiology of CADASIL disease. Med Clin (Barc) 2010;135:222-30.

17. Pantoni L, Sarti C, Pescini F, Bianchi S, Bartilini L, et al. Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol 2004;11:782-7.

18. Schmidley JW, Beadle BA, Trigg L. Co-occurrence of CADASIL and isolated CNS angiitis. Cerebrovasc Dis 2005;19:352-4.

19. Nannucci S, Pescini F, Valenti R, Ciolli L, Bianchi S, et al. Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia. Aging Clin Exp Res 2010;22:98-9.

20. Kusaba T, Hatta T, Kimura T, Sonomura K, Tanda S, et al. Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Clin Nephrol 2007;67:182-7.

21. Ragno M, Trojano L, Pianese L, Boni MV, Silvestri S, et al. Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): report of a case with a six-year follow-up. Histol Histopathol 2012;27:1307-14.

22. Chabriat H, Vahedi K, Bousser MG, Iba-Zizen MT, Joutel A, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-9.

23. Dichgans M, Wick M, Gasser T. Cerebrospinal fluid findings in CADASIL. Neurology 1999;53:233.

24. Hinze S, Goonasekera M, Nannucci S, Quaghebeur G, Briley D, et al. Longitudinally extensive spinal cord infarction in CADASIL. Pract Neurol 2015;15:60-2.

25. Pinto WB, Souza PV, Oliveira AS. Longitudinally extensive transverse myelopathy in a patient with CADASIL. Arq Neuropsiquiatr 2015;73:812.

26. Bentley P, Wang T, Malik O, Nicholas R, Ban M, et al. CADASIL with cord involvement associated with a novel and atypical NOTCH3 mutation. J Neurol Neurosurg Psychiatry 2011;82:855-60.

27. Collongues N, Derache N, Blanc F, Labauge P, de Seze J, et al. Inflammatory-like presentation of CADASIL: a diagnostic challenge. BMC Neurol 2012;12:78.

28. Schiess N, Huether K, Szolics M, Agarwal G, El-Hattab AW, et al. Multiple sclerosis or “inflammatory CADASIL?”: Case Report and review of the literature. Clin Neurol Neurosurg ; doi: 10.1016/j.clineuro.2018.01.035.

29. Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia? Neurology 2012;78:221-3.

30. Rampal R, Luther KB, Haltiwanger RS. Notch signaling in normal and disease States: possible therapies related to glycosylation. Curr Mol Med 2007;7:427-45.

31. Jurynczyk M, Jurewicz A, Raine CS, Selmaj K. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J Immunol 2008;180:2634-40.

32. Monet-Leprêtre M, Haddad I, Baron-Menguy C, Fouillot-Panchal M, Riani M, et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3ECD: a new pathomechanism in CADASIL. Brain 2013;136:1830-45.

33. Kavanagh D, Spitzer D, Kothari PH, Shaikh A, Liszewski MK, et al. New roles for the major human 3’-5’ exonuclease TREX1 in human disease. Cell Cycle 2008;7:1718-25.

34. Finsterer J, Zarrouk-Mahjoub S. Autoimmunity in MELAS. Ann Clin Lab Sci 2018;48:255-6.

35. Harris MO, Walsh LE, Hattab EM, Golomb MR. Is it ADEM, POLG, or both? Arch Neurol 2010;67:493-6.

36. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010;133:771-86.

37. Koutroulou I, Karapanayiotides T, Grigoriadis N, Karacostas D. CADASIL presenting with spontaneous intracerebral hemorrhage: report of a case and description of the first family in Northern Greece. Hippokratia 2016;20:76-9.